Statement of Delegation of Authority, 9353 [2011-3587]

Download as PDF Federal Register / Vol. 76, No. 33 / Thursday, February 17, 2011 / Notices inadequate time for all comments to be heard on March 14, 2011. Additional Information: Contact CAPT Juliana Sadovich, RN, PhD, Director, Office of Human Services Emergency Preparedness and Response, e-mail Juliana.Sadovich@acf.hhs.gov or call (202) 401–9306. SUPPLEMENTARY INFORMATION: The National Commission on Children and Disasters is an independent Commission directed to conduct a comprehensive study to examine and assess the needs of children as they relate to preparation for, response to, and recovery from all hazards, building upon the evaluations of other entities and avoiding unnecessary duplication by reviewing the findings, conclusions, and recommendations of these entities. The Commission submitted reports to the President and the Congress on the Commission’s independent and specific findings, conclusions, and recommendations to address the needs of children as they relate to preparation for, response to, and recovery from all hazards, including major disasters and emergencies. Dated: February 10, 2011. David A. Hansell, Acting Assistant Secretary for Children and Families. [FR Doc. 2011–3603 Filed 2–16–11; 8:45 am] BILLING CODE 4184–06–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration jlentini on DSKJ8SOYB1PROD with NOTICES Statement of Delegation of Authority Notice is hereby given that I have delegated to the Administrator, Health Resources and Services Administration (HRSA), the authorities vested in the Secretary under Section 4101(a) of the Patient Protection and Affordable Care Act (Pub. L. 111–148) (42 U.S.C. 280h– 4), as amended hereafter, and Section 4101(b) of the Patient Protection and Affordable Care Act (Pub. L. 111–148) amending Section 399Z–1 of the Public Health Service Act (42 U.S.C. 280h–5), as amended hereafter. These authorities may be redelegated. This delegation excludes the authority to issue regulations, to establish advisory committees and councils, and appoint their members, and to submit reports to Congress, and shall be exercised in accordance with the Department’s applicable policies, procedures, and guidelines. I herby affirm and ratify any actions taken by the Administrator, HRSA, or VerDate Mar<15>2010 16:38 Feb 16, 2011 Jkt 223001 other HRSA officials, which involved the exercise of these authorities prior to the effective date of this delegation. This delegation is effective upon date of signature. Dated: February 10, 2011. Kathleen Sebelius, Secretary. [FR Doc. 2011–3587 Filed 2–16–11; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Statement of Delegation of Authority Notice is hereby given that I have delegated to the Administrator, Health Resources and Services Administration (HRSA), the authority vested in the Secretary under Section 10502 of the Patient Protection and Affordable Care Act, as amended hereafter, as it pertains to the functions assigned to HRSA. This authority may be redelegated. This delegation excludes the authority to issue regulations, to establish advisory committees and councils, and appoint their members, and to submit reports to Congress, and shall be exercised in accordance with the Department’s applicable policies, procedures, and guidelines. I hereby affirm and ratify any actions taken by the Administrator, HRSA, or other HRSA officials, which involved the exercise of this authority prior to the effective date of this delegation. This delegation is effective upon date of signature. Dated: February 10, 2011. Kathleen Sebelius, Secretary. [FR Doc. 2011–3586 Filed 2–16–11; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 9353 discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; Quantitative Imaging for Evaluation of Responses to Cancer Therapies. Date: March 2, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Gerald G. Lovinger, PhD, Scientific Review Administrator, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8101, Bethesda, MD 20892–8329, 301/496–7987, lovingeg@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; The Role of Microbial Metabolites in Cancer Prevention and Etiology. Date: March 7, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852. Contact Person: Gerald G. Lovinger, PhD, Scientific Review Administrator, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8101, Bethesda, MD 20892–8329, 301/496–7987, lovingeg@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Quantitative Imaging for Tumor Microenvironment. Date: March 9, 2011. Time: 8 a.m. to 10 a.m. Agenda: To review and evaluate contract proposals. Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852. Contact Person: Zhiqiang Zou, MD, PhD, Scientific Review Officer, National Cancer Institute, National Institutes of Health, 6116 Executive Blvd., Room 8055A, Bethesda, MD 20852, zouzhiq@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Development of Image Processing and Analysis Software for Oncology. Date: March 9, 2011. Time: 10 a.m. to 6 p.m. Agenda: To review and evaluate contract proposals. Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852. Contact Person: Zhiqiang Zou, MD, PhD, Scientific Review Officer, National Cancer Institute, National Institutes of Health, 6116 Executive Blvd., Room 8055A, Bethesda, MD 20852, zouzhiq@mail.nih.gov. E:\FR\FM\17FEN1.SGM 17FEN1

Agencies

[Federal Register Volume 76, Number 33 (Thursday, February 17, 2011)]
[Notices]
[Page 9353]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-3587]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Statement of Delegation of Authority

    Notice is hereby given that I have delegated to the Administrator, 
Health Resources and Services Administration (HRSA), the authorities 
vested in the Secretary under Section 4101(a) of the Patient Protection 
and Affordable Care Act (Pub. L. 111-148) (42 U.S.C. 280h-4), as 
amended hereafter, and Section 4101(b) of the Patient Protection and 
Affordable Care Act (Pub. L. 111-148) amending Section 399Z-1 of the 
Public Health Service Act (42 U.S.C. 280h-5), as amended hereafter. 
These authorities may be redelegated.
    This delegation excludes the authority to issue regulations, to 
establish advisory committees and councils, and appoint their members, 
and to submit reports to Congress, and shall be exercised in accordance 
with the Department's applicable policies, procedures, and guidelines.
    I herby affirm and ratify any actions taken by the Administrator, 
HRSA, or other HRSA officials, which involved the exercise of these 
authorities prior to the effective date of this delegation.
    This delegation is effective upon date of signature.

    Dated: February 10, 2011.
Kathleen Sebelius,
Secretary.
[FR Doc. 2011-3587 Filed 2-16-11; 8:45 am]
BILLING CODE 4165-15-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.